(Q57312498)

1

0 references

Elisabetta Cerbai

object named as

Elisabetta Cerbai

6

0 references

author name string

Laura Comini

2

0 references

Silvia Suffredini

3

0 references

Muriel Bouly

5

0 references

Alessandro Mugelli

7

0 references

Roberto Ferrari

American Journal of Physiology Heart and Circulatory Physiology

8

0 references

publication date

January 2011

0 references

published in

0 references

volume

300

0 references

issue

1

0 references

page(s)

H366-H373

0 references

cites work

Ionic basis of ventricular arrhythmias in remodeled rat heart during long-term myocardial infarction.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Transient outward potassium current and Ca2+ homeostasis in the heart: beyond the action potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

The stunned myocardium: prolonged, postischemic ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Effect of long-term heart rate reduction by If current inhibition on pressure overload-induced heart failure in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Effect of Graded Heart Rate Reduction with Ivabradine on Myocardial Oxygen Consumption and Diastolic Time in Exercising Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Contributions of heart rate and contractility to myocardial oxygen balance during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Diminished Kv4.2/3 but not KChIP2 levels reduce the cardiac transient outward K+ current in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Interaction between transcription factors Iroquois proteins 4 and 5 controls cardiac potassium channel Kv4.2 gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Is the failing heart energy starved? On using chemical energy to support cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Potential novel pharmacological therapies for myocardial remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Atrial natriuretic peptide modulates the hyperpolarization-activated current (If) in human atrial myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Heart rate reduction during exercise-induced myocardial ischaemia and stunning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

The failing heart--an engine out of fuel

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Electrophysiological remodeling in hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Anti-Ischemic Effects of Ivabradine, a Selective Heart Rate-Reducing Agent, in Exercise-Induced Myocardial Ischemia in Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009

Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01117.2009